ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Jumpcode Genomics ('Jumpcode'), a life science tools company ...
The agreement grants Jumpcode access to ERS' CRISPR/Cas9 patent portfolio, empowering the company to advance the sensitivity and efficiency of next-generation sequencing (NGS) and expand ...
Epicrispr Biotechnologies to Begin Clinical Trials for its Lead Epigenetic Therapy for FSHD Patients
The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.
CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...
We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Heron ...
Lockin, the global leader in vein recognition technology, continues to redefine smart security with the Veno series smart locks. Holding the TOP 1 position worldwide in the vein smart lock industry, ...
Direct-to-consumer Genetic DNA Tests Market Size and ForecastThe Direct-to-consumer (DTC) genetic DNA testing market has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback